(Press-News.org) Chicago, October 30, 2014—Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ (AIS), according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. The Symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and The University of Chicago Medicine.
Lung adenocarcinoma accounts for 60 percent of all non-small cell lung cancers and is the most common form of lung cancer in both smokers and non-smokers and patients younger than 45 years old. Bronchioloalveolar carcinoma is a type of adenocarcinoma that affects the cells lining the alveoli (small air sacs) of the lungs. Invasion occurs when the tumor extends beyond the alveolar lining and evokes a fibroblastic stromal response. These types of tumors, if ≤3 cm in size, are reclassified as AIS (no tumor invasion) or MIA (≤0.5 cm of tumor invasion), according to the 2011 IASLC/American Thoracic Society /European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma. This study examines the difference in DFS and OS rates for patients with diseases classified as AIS and MIA and determines if it is beneficial to categorize tumors according to additional sub-types.
The study authors conducted a comprehensive search of studies published from 2011 to 2014 in the MEDLINE®, Embase and Cochrane databases. Studies selected for analysis provided survival outcome data for at least eight cases classified as AIS or MIA based on the 2011 IASLC/ATS/ERS classification. Excluded studies did not report survival information. A systematic analysis of DFS and OS data was performed using the random effect model of the Comprehensive Meta Analysis (Version 2.2) software.
The study's analysis included information from 18 clinical studies published from 2011 and 2014. (Note: Author-updated data is included in this release vs. the abstract.) The 18 studies included a total of 863 patients, with 451 patients classified as AIS and 344 patients classified as MIA. One study reported survival data on patients (68) with AIS and MIA grouped together. The median age of all patients was 67.5 years old. Sixty-one percent (526) of patients were female, and 43 percent (371) of all patients were smokers. The median tumor size was 1.3 cm.
The five-year DFS and OS rates were not statistically different between patients with AIS and MIA. The five-year DFS rate was 97.7 percent for all patients included in the analysis. The five-year DFS rate was 97 percent in patients with AIS and 96.7 percent in patients with MIA (p=0.34). The five-year OS rate was 97.3 percent for all patients included in the analysis. The five-year OS rate was 97.5 percent in patients with AIS and 96 percent in patients with MIA (p=0.58).
"Some researchers have advocated that AIS and MIA should have separate categorization," said lead author Madhusmita Behera, PhD, associate director of research in the Department of Hematology and Medical Oncology at Winship Cancer Institute of Emory University in Atlanta. "Our analysis demonstrates that these carcinomas, especially when the tumor is 3 centimeters or less in size, are associated with excellent survival outcomes; therefore, tumor sub-classification into AIS and MIA may not provide additional prognostic information."
INFORMATION:
The abstract, "Lung Adenocarcinoma Staging Based on 2011 IASLC/ATS/ERA Classification: A Pooled Analysis Of Adenocarcinoma In-situ (AIS) And Minimally Invasive Adenocarcinoma (MIA)," will be presented during the Poster Viewing Session at 5:00 p.m. Central time on Thursday, October 30, 2014. To speak with Dr. Behera, please call Michelle Kirkwood on October 30 – 31, 2014, in the ASTRO Press Office at the Chicago Marriott Downtown Magnificent Mile at 312-595-3150, or email michellek@astro.org.
The 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology will provide a clinically relevant, multidisciplinary update on the scientific progress in treating thoracic malignancies. The symposium brings together physician specialists and practicing clinicians of the multidisciplinary care team to discuss the evolving management of thoracic cancers. The Symposium integrates scientific abstract presentations with accompanying discussions, poster abstract presentations, as well as "challenging case" presentations in interactive tumor board-style forums. The two keynote speakers for the Symposium are Kenneth Rosenzwieg, MD, FASTRO, of Mount Sinai School of Medicine in New York, and Corey J. Langer, MD, of Abramson Cancer Center in Philadelphia. Dr. Rosenzwieg will discuss the use of mutational analysis to guide systemic therapy; and Dr. Langer will review the cutting edge, lung cancer research presented at recent national meetings – ASCO, ASTRO and STS (Society of Thoracic Surgeons).
2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
News Briefing, Thursday, October 30, 2014, 7:00 a.m. Central time
Poster Presentation: Thursday, October 30, 2014, 5:00 CT, Chicago Ballroom, Chicago Marriott Downtown Magnificent Mile
104 Lung Adenocarcinoma Staging Based On 2011 IASLC/ATS/ERS Classification: A Pooled Analysis Of Adenocarcinoma In-situ (AIS) And Minimally Invasive Adenocarcinoma (MIA)
Author Block: M. Behera, C. Steuer, A. Gal, T. Owonikoko, F. Khuri, S. Ramalingam, G. Sica, Winship Cancer Institute of Emory University, Atlanta, GA
Purpose/Objective(s): Lung adenocarcinoma accounts for almost 60% of all non-small cell lung cancers. According to the 2011 IASLC/ATS/ERS classification, bronchioloalveolar carcinoma that are ≤ 3 cm in size are reclassified as AIS (no invasion) and MIA (≤ 0.5 cm invasion) with pTis (adenocarcinoma) and pT1(mia) sub-categories being proposed. We conducted a systematic analysis of available data from the literature to evaluate the prognostic differences between AIS and MIA.
Materials/Methods: A comprehensive search of published studies was conducted from electronic databases (MEDLINE, EMBASE, Cochrane) using relevant search criteria. Clinical studies that reported outcomes on at least 8 cases classified as AIS or MIA using the 2011 IASLC/ATS/ERS criteria was selected for this analysis. Studies were excluded if they did not report any survival information. Data was collected on patient demographics, tumor pathology, disease free survival (DFS) and overall survival (OS). A systematic analysis of extracted data was performed using Comprehensive Meta Analysis (Version 2.2) software under the random effect model.
Results: Fourteen studies published between 2011-2014 were eligible for this analysis. A total of 642 patients were included (AIS-296; MIA-278; one study reported AIS+MIA together-68). Median age of the patients was 67.5 years (females-61%, smokers-37%). Median tumor size was 1.2 cm. The 5-year DFS rate for the whole population was 97.7%. There was no difference between the 5-year DFS rate between AIS and MIA groups (96.5% vs. 96.6%; p=0.2). The 5-year OS rate for the entire group was 97.9%. The 5-year OS rate for AIS population was equivalent to that of MIA population (97.1% vs. 96.9%; p=0.4). The 5-year DFS and OS rate was 100% in nearly all studies that reported the data.
Conclusions: There are no differences in survival rates when lung adenocarcinoma patients are staged according to the proposed 2011 IASLC/ATS/ERS pTis(adenocarcinoma) and pT1(mia) categories and raises questions regarding the necessity to classify tumors into these sub-types.
Author Disclosure Block: M. Behera: None. C. Steuer: None. A. Gal: None. T. Owonikoko: None. F. Khuri: None. S. Ramalingam: None. G. Sica: None.
Lung cancer patients with MIA have comparable 97.7 percent 5-year survival as patients with AIS
2014-10-30
ELSE PRESS RELEASES FROM THIS DATE:
Researchers find bat influenza viruses unlikely threaten human health
2014-10-30
MANHATTAN, Kansas — Bats seen at Halloween this year may not be quite as scary as they appear – at least when it comes to the spread of specific viruses. A research project conducted in part by a team of researchers in the College of Veterinary Medicine at Kansas State University suggests that influenza viruses carried by bats pose a low risk to humans.
"Bats are natural reservoirs of some of the most deadly zoonotic viruses, including rabies virus, Ebola virus, Henipaviruses and SARS coronavirus," said Wenjun Ma, one of the lead investigators and an assistant ...
Pterostilbene, a molecule similar to resveratrol, as a potential treatment for obesity
2014-10-30
This news release is available in Spanish.
Obesity is a chronic disease caused by a whole range of factors and defined as an excessive accumulation of body fat. It is a metabolic disease very prevalent in developed countries and a significant risk factor for developing certain pathologies and alterations like insulin resistance, diabetes, fatty liver, alterations in plasma lipids and hypertension, among others.
The traditional guidelines for preventing and treating obesity include following a low-calorie diet and doing moderate physical activity over the long ...
Can parents make their kids smarter?
2014-10-30
TALLAHASSEE, Fla. — Reading bedtime stories, engaging in conversation and eating nightly dinners together are all positive ways in which parents interact with their children, but according to new research, none of these actions have any detectable influence on children's intelligence later in life.
Florida State University criminology professor Kevin Beaver examined a nationally representative sample of youth alongside a sample of adopted children from the National Longitudinal Study of Adolescent Health (Add Health) and found evidence to support the argument that ...
New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs
2014-10-30
New Rochelle, NY, October 30, 2014—Oligonucleotide-based therapeutics present unique challenges when it comes to testing their potential to cause reproductive and developmental harm. New consensus guidelines for toxicity testing that take into consideration the combined chemical and biological characteristics of these novel biopharmaceuticals are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available free on the Nucleic Acid Therapeutics website until November 30, 2014.
Joy Cavagnaro, Access ...
Breakdown in gut barriers to bacteria may promote inflammation and craving in alcoholics
2014-10-30
Philadelphia, PA, October 30, 2014 – Bacteria in the gastrointestinal tract fulfill many vital functions and are critical for digestion. Yet, these same bacteria can induce strong inflammatory responses by the immune system if they penetrate the gut and enter the bloodstream.
Although acute inflammation is a natural response to protect the body, chronic or systemic inflammation is linked to numerous disorders and diseases. Prior research has established the involvement of inflammatory processes in the development of psychiatric disorders, including major depression ...
Sadness lasts longer than other emotions
2014-10-30
New York | Heidelberg, 30 October 2014 Why is it that you can feel sad up to 240 times longer than you do feeling ashamed, surprised, irritated or even bored? It's because sadness often goes hand in hand with events of greater impact such as death or accidents. You need more time to mull over and cope with what happened to fully comprehend it, say Philippe Verduyn and Saskia Lavrijsen of the University of Leuven in Belgium. Their research, published in Springer's journal Motivation and Emotion, is the first to provide clear evidence to explain why some emotions last a longer ...
Campaign to reduce firearm suicide wins support among firearm retailers in New Hampshire
2014-10-30
Boston, MA — Nearly half (48%) of firearm retailers in New Hampshire displayed materials from a firearm suicide prevention campaign generated by a coalition of gun owners and public health professionals, according to a new study led by Harvard School of Public Health (HSPH) researchers. It is the first collaboration between firearm retailers and public health professionals around suicide prevention.
The study appeared online October 28, 2014 in Suicide and Life-Threatening Behavior.
Following a spate of suicides in 2009 in New Hampshire involving recently-purchased ...
Yale finds a planet that won't stick to a schedule
2014-10-30
New Haven, Conn. – For their latest discovery, Yale astronomers and the Planet Hunters program have found a low-mass, low-density planet with a punctuality problem.
The new planet, called PH3c, is located 2,300 light years from Earth and has an atmosphere loaded with hydrogen and helium. It is described in the Oct. 29 online edition of The Astrophysical Journal.
The elusive orb nearly avoided detection. This is because PH3c has a highly inconsistent orbit time around its sun, due to the gravitational influence of other planets in its system. "On Earth, these effects ...
Screening patients at high-risk for lung cancer more likely when prmary care provider is familiar with guidelines
2014-10-30
Chicago, October 30, 2014—Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. The Symposium is sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), the International Association for the Study of Lung Cancer (IASLC) and ...
Reef-builders with a sense of harmony
2014-10-30
They live in the cold, dark depths of the oceans, are often exposed to strong currents and provide a stable base for diverse and colourful ecosystems: Stony corals of the species Lophelia pertusa are considered excellent reef-builders. According to the latest findings of researchers from the Heriot-Watt University Edinburgh, GEOMAR Helmholtz Centre for Ocean Research Kiel, the University of Glasgow and the United States Geological Survey, even genetically different individuals are able to fuse their skeletons. On an expedition with the German submersible JAGO and the research ...